Concomitant paraganglioma and thyroid carcinoma: A case report

Table 1 Literature review

Author (yr)	Topography	Diagnosis	Genetic testing
Rasquin et al[11], 2018	Adrenal	PTC and PHEO	EGLN1, FH, KIF1B, MEN1, NF1, RET, SDHAF2, SDHC, SDHD, TMEM127, VHL, and SDHA: (-)
Bugalho, et al[7], 2015	Carotid body	PTC and PGL/PHEO	VHL, SDHB, SDHC, SDHD, SDHAF2, TMEM127, MAX, PTEN: (-)
	Adrenal	PTC and PGL/PHEO	SDHB (+)
	Adrenal	PTC and PGL/PHEO	VHL, SDHB, SDHC, SDHD, SDHAF2, TMEM127, MAX, PTEN: (-)
	Adrenal	PTC and PGL/PHEO	SDHB (+)
Huguet et al[12], 2013	Adrenal	PTC and PGLs	SDHD (+)
Papathomas et al[13], 2013	Carotid body	PTC and PGL and PHEO	SDHD (+)
Sisson et al[8], 2012	Adrenal	PTC and PHEO and PA	Not performed
Nasser et al[14], 2009	Adrenal	PTC and PHEO	RET: (-)
Zbuk et al[15], 2007	Carotid body	PTC and PGLs	PTEN (+), SDHC (+)
Yang et al[16], 2007	Adrenal	PTC and PHEO and PGL	RET, VHL, SDHB, SDHD: (-)
Hashiba et al[17], 2006	Adrenal	PTC and PHEO	Not performed
Neumann et al[18], 2004	Adrenal	PTC and PGL	SDHB (+)
	Adrenal	PTC and PGL	SDHD (+)

PTC: Papillary thyroid carcinoma; PHEO: Pheochromocytoma; PGL: Paraganglioma; PA: Pituitary adenoma; SDHD: Succinate dehydrogenase subunit D; SDHB: Succinate dehydrogenase subunit B; VHL: Von Hippel-Lindau mutation.